The Valley Desk

NCT02301039 · Interventional trial

SARC028: A Phase II Study of the Anti-PD1 Antibody Pembrolizumab (MK-3475) in Patients With Advanced Sarcomas

Overall registry status Completed

Phase 2

Conditions Bone Sarcoma, Soft Tissue Sarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov